Artificial Intelligence

Predictive Oncology rebrands as Axe Compute, betting its future not on algorithms, but on solving the critical shortage of AI compute power. A deep dive.

Serve Robotics just deployed the largest U.S. sidewalk delivery fleet. We dive into the tech, the competition, and the high-stakes economics of this silent revolution.

A new AI-powered diagnostic test provides unprecedented clarity for millions at risk of esophageal cancer, challenging the old 'watch and wait' model.

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.

Creekstone Energy plans to add 2 gigawatts of nuclear power to its Utah Gigasite, a bold move to satisfy AI's insatiable energy appetite.

Bunker Hill Mining is pairing a strategic land grab with AI-driven exploration, a dual-pronged strategy aiming to revitalize a legendary American mining district.

Guinness World Records crowns a new king of fragrance. Inside the AI-powered, record-breaking Xuelei Fragrance Museum in Guangzhou, China.

Tech Mahindra's Global Chess League is partnering with AWS, using AI and smart broadcasting to transform the ancient game into a high-tech spectator sport.

New AI voice agents promise to capture millions in lost revenue for med spas by working after hours. Is this the future of the aesthetic care market?

Malaysia's Treasure Global secures fresh capital, but a brutal market reaction and high cash burn raise questions about its super app's future.

Long Beach's new Black-Serving Institution status isn't just an equity win; it's a strategic investment in the diverse STEM talent America's defense sector needs.

The private capital market leader's latest user-voted award reveals a major trend: authentic customer feedback is the new currency in high-stakes investing.

Serina Therapeutics poaches a top chemist to expand its POZ platform, signaling a major push beyond Parkinson's into new, high-value drug markets.

Compass predicts a balanced 2026 housing market, but a deeper look reveals a split: modest relief for many and a luxury boom fueled by AI-driven wealth.

A new partnership between KBRA Analytics and Intex Solutions streamlines CMBS analysis, promising to enhance risk management in volatile economic times.

Tenaya Therapeutics unveils promising interim data for its ARVC gene therapy, TN-401, hinting at a potential cure and igniting investor interest.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.